CN
About Us
Company Profile
Management Team
Milestones
Corporate Culture
Science & Technology
R&D Center
Pipeline
Manufacturing Park
Cooperation
Expanded Access Policy
Investor Relations
Corporate Governance
Information Disclosure
Financial Reports
Stock Information
IR Calendar
Investor Presentations
Email Alerts
News
Latest News
Media
Join Us
Culture & Benefits
Contact Us
Contact Information
Consultation
Legal Statement
Privacy
CN
About Us
Company Profile
Management Team
Milestones
Corporate Culture
Science & Technology
R&D Center
Pipeline
Manufacturing Park
Cooperation
Expanded Access Policy
Investor Relations
Corporate Governance
Information Disclosure
Financial Reports
Stock Information
IR Calendar
Investor Presentations
Email Alerts
News
Latest News
Media
Join Us
Culture & Benefits
Contact Us
Contact Information
Consultation
Legal Statement
Privacy
Latest News
Media
News
Latest News
Media
More
Keymed Biosciences releases 2021 annual results
March 29, 2022, Chengdu, China - Keymed Biosciences Inc (HKEX: 02162) released 2021 annual results BUSINESS
2022-03-29
More
Keymed has been included as eligible stocks of the Shenzhen-Hong Kong Stock Connect
March 7, 2022, Chengdu, China -Keymed Biosciences Inc. (HKEX:02162) is pleased to announce that the shares of the C
2022-03-07
More
Keymed Bio joins Hang Seng Family of Indexes
February 18, 2022, Hong Kong – According to the quarterly review results of Hang Seng Family of Indexes, Keymed
2022-02-18
More
Keymed and InnoCare jointly announce dosing of first patient in clinical trial of CD20xCD3 bispecific antibody CM355
Chengdu, Jan. 18, 2022 –Keymed Biosciences (HKEX: 02162) and InnoCare Pharma (HKEX: 09969) jointly announced today...
2022-01-18
13条
上一页
1
2
下一页